The Evaluation of Intelligence Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life for Newly Diagnosed Non-metastatic Breast Cancer Women: Randomized Controlled Trial.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- National Yang Ming Chiao Tung University
- Enrollment
- 112
- Locations
- 1
- Primary Endpoint
- Baseline EORTC QLQ-C30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The aim of this study was to investigate the quality of life (QoL) for women with breast cancer in Taiwan after using the BCSMS App.
Detailed Description
After receiving their first diagnosis of breast cancer, women with stage 0 to III were randomized into intervention and control groups. Intervention group subjects used BCSMS App and the control group subjects received usual care. Two questionnaires: EORTC QLQ-C30 and EORTC QLQ-BR 23 were distributed to subjects in both arms at baseline and at 1.5 and 3 months. All evaluations were anonymous.
Investigators
I-Ching Hou
Assistant Professor
National Yang Ming Chiao Tung University
Eligibility Criteria
Inclusion Criteria
- •first diagnosis of breast cancer with stage 0 to III in past year.
- •aged 20 to 65 years
- •had an Android/iOS smartphone;
- •able to read and write in Chinese;
- •willing to participate in the study and provide informed consent.
Exclusion Criteria
- •not matched to inclusion criteria
- •mental illness
- •serious illness and life-threatening
Outcomes
Primary Outcomes
Baseline EORTC QLQ-C30
Time Frame: Baseline
Baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3). The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
Change of EORTC QLQ-C30 at 3 month
Time Frame: the 3rd month
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to the 3rd month. The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
Change of EORTC QLQ-C30 at 1.5 month
Time Frame: 1.5 month
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to 1.5 month.The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
Secondary Outcomes
- Baseline EORTC QLQ-BR23(Baseline)
- Change of EORTC QLQ-BR23 at 1.5 month(1.5 month)
- Change of EORTC QLQ-BR23 at 3 month(the 3rd month)